Inventor · disambiguated record
Claude Morel
Also filed as: MOREL CLAUDE · NAJER HENRY
11 granted patents·95 citations·filing 1977–1993
89Inventor score
Files withSYNTHELABO11
Top patents by PatentIndex Score
11 records- 0187US4977159A2-[(4-piperidyl)methyl]-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole derivatives, and their application in treating depressive state, anxiety state or hypertensionSYNTHELABO·Filed 1988·Granted Dec 11, 1990·46 cites·5 claims
- 0281US4277476ADerivatives of fluorenes and fluoranthenes and process for their preparationSYNTHELABO·Filed 1979·Granted Jul 7, 1981·11 cites·8 claims
- 0377US4567177AImidazoline derivatives as α2 -antagonistsSYNTHELABO·Filed 1984·Granted Jan 28, 1986·9 cites·4 claims
- 0464US4358451APyrimido- and imidazo-pyridoindole derivativesSYNTHELABO·Filed 1980·Granted Nov 9, 1982·9 cites·7 claims
- 0560US4190657ANaphthyridine derivativesSYNTHELABO·Filed 1977·Granted Feb 26, 1980·6 cites·13 claims
- 0657US4272539APyridoindole derivativesSYNTHELABO·Filed 1980·Granted Jun 9, 1981·5 cites·4 claims
- 0756US4617313AAlpha2 -antagonistic 2-(4,5-dihydro-1H-imidazol-2-yl)-pyrrolo[3,2,1-hi]indolesSYNTHELABO·Filed 1985·Granted Oct 14, 1986·4 cites·4 claims
- 0849US4336256APyridoindole derivativesSYNTHELABO·Filed 1980·Granted Jun 22, 1982·3 cites·5 claims
- 0937US4931449A2-((4-piperidyl)methyl)benzofuro(2,3-C)pyridine derivatives, and their application in therapySYNTHELABO·Filed 1988·Granted Jun 5, 1990·1 cites·4 claims
- 1035US4904684A2-(4,5-dihydro-1H-imidazol-2-yl)-1,2,4,5-tetrahydropyrrolo[3,2,1-hi]indole derivatives useful as antidiabetic agentsSYNTHELABO·Filed 1988·Granted Feb 27, 1990·1 cites·5 claims
- 1131US5418248A2-thienylimidazo[2,1-β]benzothiazole-3-acetic acid derivatives, their preparation and their useSYNTHELABO·Filed 1993·Granted May 23, 1995·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Claude Morel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →